YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(7)
- Austria(1)
- Belgium(3)
- Canada(50)
- China(17)
- Colombia(1)
- Denmark(1)
- Finland(1)
- France(9)
- Germany(35)
- Greece(2)
- Hong Kong(1)
- Hungary(2)
- India(66)
- Ireland(1)
- Israel(3)
- Italia (5)
- Japan(1)
- Latvia(1)
- Luxembourg(1)
- Mexico(2)
- Peru(1)
- Poland(1)
- Portugal(4)
- Singapore(1)
- Slovenia(2)
- South Korea(5)
- Spain(10)
- Sweden(2)
- Switzerland(22)
- Taiwan(2)
- The Czech Republic(1)
- The Netherlands(5)
- Turkey(1)
- Ukraine(2)
- United Kingdom(46)
- United States(619)
- Vietnam(1)
Contract Service Directory
Integral BioSystems
Company Headquarters
23 Crosby Drive Suite 100A
Bedford, MA 01730
United States
Company Description
Integral BioSystems, LLC is a contract research organization (CRO) with service niches in Drug Delivery R&D, Drug Development and Intellectual Property. The company, based in the Boston area, specializes in the design and development of dosage forms for ophthalmic, transdermal, intravenous, intranasal and oral routes of drug administration.
Contract Service Directory
- Analytical Methods Development
- API Solubilization Technologies
- Bioanalytical Analysis LC/MS/MS
- CMC (Chemistry, Manfacturing & Controls)
- Contract Research
- Dissolution Testing
- Drug Delivery Systems
- Formulation Development
- HPLC
- Particle Size Analysis
- Preclinical Testing Formulations
- Scale-Up
- Stability Studies
- Sustained Release Delivery Systems
- Technology Transfer
Content From Integral BioSystems
-
Ocular Drug Delivery: Review of Present Technologies and Steps Forward
Market research estimates performed in the last 6 months have shown that the market size for ophthalmic medications is expected to reach more than 25 billion, by the year 2015. The ophthalmology drugs market classification is based on the type of drugs: treatment-based drugs, over-the-counter (OTC) drugs and ocular anesthetics.White Papers / Tech Papers Released on 10.28.2014
Related Content
-
Bio News | Breaking News | Industry News
Entera Bio Establishes U.S. HQ in Wellesley, MA
Jonathan Lieber will serve as the company's U.S.-based chief financial officer11.21.19
-
Federal Equipment's Adam Covitt
Federal Equipment's vice president was on hand at Contract Pharma 2019.
-
-
The Role of Technology Within Regulatory Compliance in Bioanalysis
Learn how current technology is playing a role in the regulatory process at PharmSci 36010.29.19
-
San Antonio Hosts AAPS PharmSci 360
Discover advances in drug development and delivery, manufacturing and packaging10.28.19
-
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
BioInvent, Cancer Research UK Sign Manufacturing Pact
Expected to generate approximately $3 million.10.23.19
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
Phillips-Medisize Inks Combination Drug Deal
Wins contract to manufacture first electronic-enabled combination drug delivery product.10.23.19
-
Clinical Trials | Drug Development
Contract Pharma’s 20th Anniversary Retrospective: Drug Development
A look back at the role of CROs in drug development and what we can expect for the futureKristin Brooks, Contract Pharma 10.16.19
-
Breaking News | Industry News
VIDEO: Federal Equipment's Adam Covitt
Federal Equipment's vice president was on hand at Contract Pharma 2019.10.02.19
-
-
Bio News | Breaking News | Industry News
Mallinckrodt to Sell CDMO BioVectra for $250M
BioVectra will continue to supply an API for Mallinckrodt's specialty brands business under a long-term deal09.10.19
-
-
Integral BioSystems to Highlight Formulation Development Expertise
Boston-area drug developer to display at Table 11709.20.18
-
Clinical Trials | Drug Delivery | Excipients
Drug Delivery Challenges
Sustained delivery formats for the treatment of eye diseaseShikha P. Barman, Integral BioSystems, LLC 10.07.15
